IRIS
MIKULSKA, MALGORZATA KAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.599
AS - Asia 2.693
NA - Nord America 1.171
SA - Sud America 243
AF - Africa 60
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.772
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.124
SG - Singapore 1.132
US - Stati Uniti d'America 1.106
CN - Cina 681
VN - Vietnam 546
FR - Francia 184
BR - Brasile 146
HK - Hong Kong 89
DE - Germania 66
FI - Finlandia 48
AR - Argentina 44
BD - Bangladesh 32
GB - Regno Unito 32
JP - Giappone 32
IN - India 31
MX - Messico 27
NL - Olanda 26
IQ - Iraq 25
CA - Canada 23
UA - Ucraina 17
EC - Ecuador 16
ID - Indonesia 15
ZA - Sudafrica 14
CH - Svizzera 12
PK - Pakistan 12
PH - Filippine 11
RU - Federazione Russa 11
ES - Italia 10
TR - Turchia 10
CO - Colombia 9
DZ - Algeria 9
KR - Corea 9
TH - Thailandia 9
UZ - Uzbekistan 9
AT - Austria 8
GR - Grecia 7
KE - Kenya 7
PY - Paraguay 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
NP - Nepal 6
PE - Perù 6
SE - Svezia 6
CL - Cile 5
ET - Etiopia 5
PL - Polonia 5
PT - Portogallo 5
TW - Taiwan 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
BH - Bahrain 3
IE - Irlanda 3
KZ - Kazakistan 3
MT - Malta 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BE - Belgio 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GA - Gabon 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
KY - Cayman, isole 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
SI - Slovenia 1
Totale 23.768
Salva come PNG Salva come JPEG
Città #
Genova 8.772
Genoa 6.717
Vado Ligure 1.721
Rapallo 1.605
Singapore 555
San Jose 369
Ho Chi Minh City 172
Lauterbourg 165
Hanoi 137
Ashburn 124
Council Bluffs 123
Beijing 118
New York 88
Hong Kong 83
Bordighera 77
Frankfurt am Main 52
Santa Clara 44
Helsinki 39
Haiphong 29
Milan 28
Tokyo 27
Da Nang 22
Los Angeles 22
Rome 18
Chicago 15
Orem 15
Biên Hòa 14
Amsterdam 13
São Paulo 13
Mexico City 11
Zurich 11
St Louis 10
Baghdad 9
City of London 9
Hải Dương 9
Kyiv 9
Lappeenranta 9
London 9
Tianjin 9
Can Tho 8
Modena 8
Toronto 8
Verona 8
Buffalo 7
Denver 7
Marseille 7
Quito 7
Tashkent 7
Guangzhou 6
Madrid 6
Nairobi 6
Paris 6
Thái Nguyên 6
Addis Ababa 5
Athens 5
Atlanta 5
Bangkok 5
Bari 5
Bra 5
Buenos Aires 5
Bắc Ninh 5
Dallas 5
Istanbul 5
Johannesburg 5
Lima 5
Montreal 5
Stockholm 5
Suzhou 5
Warsaw 5
Amman 4
Bologna 4
Bắc Giang 4
Cardiff 4
Catania 4
Curitiba 4
Des Moines 4
Dhaka 4
Florence 4
Houston 4
Jakarta 4
Karachi 4
Lahore 4
Lisbon 4
Medellín 4
Nha Trang 4
Ninh Bình 4
Rio de Janeiro 4
Santiago 4
Santo Domingo 4
Seoul 4
Thái Bình 4
Trento 4
Asunción 3
Boardman 3
Brasília 3
Bratislava 3
Cairo 3
Carapicuíba 3
Charlotte 3
Chennai 3
Totale 21.565
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 236
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 229
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 228
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 213
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). 211
Bacterial infections in hematopoietic stem cell transplantation recipients. 194
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 190
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 189
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 188
Use of colistin in adult patients: a cross-sectional study 185
Bacterial infections in hematopoietic stem cell transplant recipients 178
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 173
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 172
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 172
Non-cultural methods for the diagnosis of invasive fungal disease 172
Invasive candidiasis in non-hematological patients. 171
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 171
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 171
Bloodstream infections in critically ill patients with COVID-19 171
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 170
De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period 170
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 169
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 168
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 168
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 164
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 164
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. 163
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 163
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 163
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 162
Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. 162
Bloodstream infections in neutropenic cancer patients: A practical update 161
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 160
Invasive mycoses in children receiving hemopoietic SCT 159
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 158
Multidrug-resistant bacteria in hematology patients: Emerging threats 156
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 156
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 155
Will new antimicrobials overcome resistance among Gram-negatives? 154
Galactomannan: testing the same sample twice? 153
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 152
Occurrence, presentation and treatment of candidemia. 151
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 149
Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. 148
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 148
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 148
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report 146
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 146
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 146
Voriconazole in clinical practice. 144
Galactomannan testing might be useful for early diagnosis of fusariosis. 144
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 143
Mortality after bloodstream infections in allogeneichaematopoietic stem cell transplant (HSCT) recipients 141
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 141
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 141
2017 ECIL 7 vaccine guidelines 141
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 138
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 137
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) 136
CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. 136
La Definizione di Aspergillosi 135
ECILrecommendations for the use of biological markers for the diagnosis of invasivefungal diseases in leukemic patients and hematopoietic SCT recipients 135
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. 134
Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis. 134
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. 133
Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter. 133
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 133
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 133
Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on. 132
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 132
Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: Results from a collaborative study involving six European clinical centers 131
Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients 130
Manuale per la gestione delle complicanze infettive nell’emato-oncologia e trapianto di midollo osseo 128
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group 128
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4) 128
Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci. 127
Invasive aspergillosis: diagnosis, prophylaxis and treatment 126
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT 126
The skin and soft tissue infections in hematological patients 126
Management of chronic viral hepatitis in the hematological patient 126
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical 126
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). 125
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. 124
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients 123
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines 122
The role of televancin in the treatment of MRSA infections in hospital 121
Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays? 121
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) 121
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 121
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 119
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 118
Current role of echinocandins in the management ofinvasive aspergillosis 117
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy 117
European survey on principles of prudent antibiotic prescribing teaching in undergraduate students 116
No report on Zika virus infection in EBMT registry: Infectious Diseases Working Party statement 115
Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities 115
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study 115
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 115
Totale 15.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.666
article - articoli 82.168
book - libri 373
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.125
Totale 169.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021435 0 0 0 0 0 0 0 0 0 187 122 126
2021/20221.741 67 48 101 233 75 168 77 414 86 179 70 223
2022/20232.076 194 139 27 181 263 285 72 138 303 132 278 64
2023/20241.477 81 168 55 189 158 217 83 107 71 47 119 182
2024/20254.357 100 324 107 304 595 426 414 733 212 219 453 470
2025/20267.338 943 307 626 706 1.030 577 1.181 478 730 760 0 0
Totale 24.313